E71.44
Other secondary carnitine deficiency
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary carnitine deficiency is a rare medical condition where the levels of carnitine, a vital nutrient for energy production in the body, become abnormally low due to reasons beyond primary genetic causes. This deficiency can impair the body’s ability to convert fat into energy, affecting various organs and tissues. Recognizing this condition involves understanding its causes, symptoms, and potential approaches to diagnosis and management.
Causes & Symptoms
Clinical Causes: Certain chronic illnesses, such as liver or kidney disease, which affect carnitine synthesis or utilization Use of specific medications, including valproic acid and other antiepileptic drugs, that deplete carnitine levels Malnutrition or dietary deficiencies that result in inadequate intake or absorption of carnitine Acute or chronic infections that can increase the body's demand for carnitine, leading to deficiency Transfer of carnitine from the bloodstream into tissues due to underlying metabolic disturbances Certain cancers or chemotherapy treatments that interfere with carnitine metabolism
Key Symptoms: Muscle weakness or fatigue Exercise intolerance Muscle cramps or pain Hypoglycemia (low blood sugar) Elevated levels of muscle enzymes in blood tests Signs of metabolic disturbances, such as nausea or abdominal discomfort In severe cases, possible neurological symptoms like developmental delays or cognitive impairment
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical assessment and laboratory tests. Blood tests measuring free and total carnitine levels are primary tools, along with urine tests for carnitine excretion. Additionally, specialized metabolic panels may be conducted to evaluate related organic acids and amino acids. Imaging studies or muscle biopsies might be used in complex cases to assess tissue involvement. A thorough medical history, including medication use and nutritional status, helps establish the underlying cause of the deficiency.
Treatment Protocols: Management of other secondary carnitine deficiency often focuses on addressing the underlying cause and replenishing carnitine levels. Common approaches include
Clinical Advice & FAQs
Billing Guidance
Is E71.44 a billable ICD-10 code?
Yes, E71.44 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.44?
Clinical documentation must specify the nature of Other secondary carnitine deficiency and any associated comorbidities for accurate reporting.
Cite this Clinical Reference